| Year |
Citation |
Score |
| 2020 |
Lu Y, Liu X, Zhang E, Kopras EJ, Smith EP, Astreinidis A, Li C, Leung YK, Ho SM, Yu JJ. Estrogen activates pyruvate kinase M2 and increases the growth of TSC2-deficient cells. Plos One. 15: e0228894. PMID 32078667 DOI: 10.1371/Journal.Pone.0228894 |
0.317 |
|
| 2018 |
Cheong A, Johnson SA, Howald EC, Ellersieck MR, Camacho L, Lewis SM, Vanlandingham MM, Ying J, Ho SM, Rosenfeld CS. Gene Expression and DNA Methylation Changes in the Hypothalamus and Hippocampus of Adult Rats Developmentally Exposed to Bisphenol A or Ethinyl Estradiol: A CLARITY-BPA Consortium Study. Epigenetics. PMID 30001178 DOI: 10.1080/15592294.2018.1497388 |
0.306 |
|
| 2017 |
Khanal T, Choi K, Leung YK, Wang J, Kim D, Janakiram V, Cho SG, Puga A, Ho SM, Kim K. Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer. Scientific Reports. 7: 10662. PMID 28878246 DOI: 10.1038/S41598-017-11106-2 |
0.334 |
|
| 2017 |
Leung YK, Govindarajah V, Cheong A, Veevers J, Song D, Gear R, Zhu X, Ying J, Kendler A, Medvedovic M, Belcher S, Ho SM. Gestational high-fat diet and bisphenol A exposure heightens mammary cancer risk. Endocrine-Related Cancer. PMID 28487351 DOI: 10.1530/Erc-17-0006 |
0.35 |
|
| 2017 |
Smithrud DB, Powers L, Lunn J, Abernathy S, Peschka M, Ho SM, Tarapore P. Ca(2+) Selective Host Rotaxane Is Highly Toxic Against Prostate Cancer Cells. Acs Medicinal Chemistry Letters. 8: 163-167. PMID 28197305 DOI: 10.1021/Acsmedchemlett.6B00347 |
0.355 |
|
| 2017 |
Leung Y, Govindarajah V, Cheong A, Song D, Zhu X, Ying J, Kendler A, Medvedovic M, Belcher S, Ho S. Abstract 4826: Maternal high butter fat intake heightens mammary cancer risk in offsprings gestationally exposed to bisphenol A at environmentally relevant dose Cancer Research. 77: 4826-4826. DOI: 10.1158/1538-7445.Am2017-4826 |
0.378 |
|
| 2017 |
Tarapore P, To S, Ouyang B, Leung Y, Cheong A, Ho S. Abstract 2537: MicroRNA targeting anti-apoptotic and G2/M pathways as therapeutic targets for castration resistant prostate cancer Cancer Research. 77: 2537-2537. DOI: 10.1158/1538-7445.Am2017-2537 |
0.342 |
|
| 2016 |
Ho SM, Rao RC, To S, Schoch E, Tarapore P. Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer. Endocrine-Related Cancer. PMID 27998958 DOI: 10.1530/Erc-16-0175 |
0.406 |
|
| 2016 |
Ho SM, Cheong A, Adgent MA, Veevers J, Suen AA, Tam NN, Leung YK, Jefferson WN, Williams CJ. Environmental Factors, Epigenetics, and Developmental Origin of Reproductive Disorders. Reproductive Toxicology (Elmsford, N.Y.). PMID 27421580 DOI: 10.1016/J.Reprotox.2016.07.011 |
0.357 |
|
| 2016 |
Cheong A, Zhang X, Cheung YY, Tang WY, Chen J, Ye SH, Medvedovic M, Leung YK, Prins GS, Ho SM. DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk. Epigenetics. 0. PMID 27415467 DOI: 10.1080/15592294.2016.1208891 |
0.303 |
|
| 2016 |
Wang Q, Trevino LS, Wong RL, Medvedovic M, Chen J, Ho SM, Shen J, Foulds CE, Coarfa C, O'Malley BW, Shilatifard A, Walker CL. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk. Molecular Endocrinology (Baltimore, Md.). 30: 856-71. PMID 27219490 DOI: 10.1210/Me.2015-1310 |
0.327 |
|
| 2016 |
Govindarajah V, Leung YK, Ying J, Gear R, Bornschein RL, Medvedovic M, Ho SM. In utero exposure of rats to high-fat diets perturbs gene expression profiles and cancer susceptibility of prepubertal mammary glands. The Journal of Nutritional Biochemistry. 29: 73-82. PMID 26895667 DOI: 10.1016/J.Jnutbio.2015.11.003 |
0.344 |
|
| 2015 |
Ho SM, Tam NN. Development: Organoid model shows effect of BPA on prostate development. Nature Reviews. Urology. PMID 26526756 DOI: 10.1038/Nrurol.2015.261 |
0.377 |
|
| 2015 |
Lam HM, Ho SM, Chen J, Medvedovic M, Tam NN. Bisphenol A disrupts HNF4α-regulated gene networks linking to prostate preneoplasia and immune disruption in Noble rats. Endocrinology. en20151363. PMID 26496021 DOI: 10.1210/En.2015-1363 |
0.366 |
|
| 2015 |
Yang S, Pinney SM, Mallick P, Ho SM, Bracken B, Wu T. Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study. Clinical Genitourinary Cancer. 13: e347-51. PMID 25972296 DOI: 10.1016/J.Clgc.2015.04.004 |
0.357 |
|
| 2015 |
Tam NN, Zhang X, Xiao H, Song D, Levin L, Meller J, Ho SM. Increased susceptibility of estrogen-induced bladder outlet obstruction in a novel mouse model. Laboratory Investigation; a Journal of Technical Methods and Pathology. 95: 546-60. PMID 25706094 DOI: 10.1038/Labinvest.2015.30 |
0.378 |
|
| 2015 |
Wong RL, Wang Q, Treviño LS, Bosland MC, Chen J, Medvedovic M, Prins GS, Kannan K, Ho SM, Walker CL. Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate. Epigenetics : Official Journal of the Dna Methylation Society. 10: 127-34. PMID 25612011 DOI: 10.1080/15592294.2015.1009768 |
0.314 |
|
| 2015 |
Wang Q, Trevino L, Prins G, Bosland M, Ho S, Medvedovic M, Walker CL. Abstract SY40-04: Reprogramming of the epigenome by MLL links early life environmental exposures to adult cancer risk Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Sy40-04 |
0.424 |
|
| 2015 |
Schade GR, Holt SK, Zhang X, Wright JL, Zhao SS, Kolb S, Lam H, Levin L, Leung Y, Ho S, Stanford J. PD47-03 EXPRESSION OF CYTOPLASMIC ERβ1 AND NUCLEAR ERβ2 IS ASSOCIATED WITH POOR OUTCOMES FOLLOWING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2747 |
0.382 |
|
| 2014 |
Yang WS, Chadalapaka G, Cho SG, Lee SO, Jin UH, Jutooru I, Choi K, Leung YK, Ho SM, Safe S, Kim K. The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis. Neoplasia (New York, N.Y.). 16: 1059-69. PMID 25499219 DOI: 10.1016/J.Neo.2014.09.011 |
0.304 |
|
| 2014 |
Leung YK, Chan QK, Ng CF, Ma FM, Tse HM, To KF, Maranchie J, Ho SM, Lau KM. Hsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer. Plos One. 9: e98037. PMID 24837491 DOI: 10.1371/Journal.Pone.0098037 |
0.368 |
|
| 2014 |
Tarapore P, Ying J, Ouyang B, Burke B, Bracken B, Ho SM. Exposure to bisphenol A correlates with early-onset prostate cancer and promotes centrosome amplification and anchorage-independent growth in vitro. Plos One. 9: e90332. PMID 24594937 DOI: 10.1371/Journal.Pone.0090332 |
0.424 |
|
| 2014 |
Knower KC, To SQ, Leung YK, Ho SM, Clyne CD. Endocrine disruption of the epigenome: a breast cancer link. Endocrine-Related Cancer. 21: T33-55. PMID 24532474 DOI: 10.1530/Erc-13-0513 |
0.325 |
|
| 2014 |
Prins GS, Hu WY, Shi GB, Hu DP, Majumdar S, Li G, Huang K, Nelles JL, Ho SM, Walker CL, Kajdacsy-Balla A, van Breemen RB. Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium. Endocrinology. 155: 805-17. PMID 24424067 DOI: 10.1210/en.2013-1955 |
0.3 |
|
| 2014 |
Wang Q, Wong RLY, Kusewitt DF, Bosland MC, Chen J, Medvedovic M, Prins GS, Kannan K, Ho S, Walker CL. Abstract 1382: Developmental exposure to BPA increases the prostate cancer susceptibility via reprogramming of androgen-responsive genes via increased H3K4me3 methylation Cancer Research. 74: 1382-1382. DOI: 10.1158/1538-7445.Am2014-1382 |
0.442 |
|
| 2013 |
Lee MT, Ho SM, Tarapore P, Chung I, Leung YK. Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12. Neoplasia (New York, N.Y.). 15: 1262-71. PMID 24339738 DOI: 10.1593/Neo.131184 |
0.549 |
|
| 2013 |
Lee MT, Leung YK, Chung I, Tarapore P, Ho SM. Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent manner. The Journal of Biological Chemistry. 288: 25038-52. PMID 23857583 DOI: 10.1074/Jbc.M113.476952 |
0.541 |
|
| 2013 |
Lee MT, Ouyang B, Ho SM, Leung YK. Differential expression of estrogen receptor beta isoforms in prostate cancer through interplay between transcriptional and translational regulation. Molecular and Cellular Endocrinology. 376: 125-35. PMID 23806560 DOI: 10.1016/J.Mce.2013.06.023 |
0.581 |
|
| 2013 |
Wu T, Wang Y, Ho SM, Giovannucci E. Plasma levels of nitrate and risk of prostate cancer: a prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1210-8. PMID 23677578 DOI: 10.1158/1055-9965.Epi-13-0134 |
0.384 |
|
| 2013 |
Brunst KJ, Leung YK, Ryan PH, Khurana Hershey GK, Levin L, Ji H, Lemasters GK, Ho SM. Forkhead box protein 3 (FOXP3) hypermethylation is associated with diesel exhaust exposure and risk for childhood asthma. The Journal of Allergy and Clinical Immunology. 131: 592-4.e1-3. PMID 23260754 DOI: 10.1016/J.Jaci.2012.10.042 |
0.64 |
|
| 2012 |
Ho SM, Johnson A, Tarapore P, Janakiram V, Zhang X, Leung YK. Environmental epigenetics and its implication on disease risk and health outcomes. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 53: 289-305. PMID 23744968 DOI: 10.1093/Ilar.53.3-4.289 |
0.537 |
|
| 2012 |
Isaac J, Tarapore P, Zhang X, Lam YW, Ho SM. Site-specific S-nitrosylation of integrin α6 increases the extent of prostate cancer cell migration by enhancing integrin β1 association and weakening adherence to laminin-1. Biochemistry. 51: 9689-97. PMID 23106339 DOI: 10.1021/Bi3012324 |
0.605 |
|
| 2012 |
Privette Vinnedge LM, Ho SM, Wikenheiser-Brokamp KA, Wells SI. The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer. Plos One. 7: e46985. PMID 23071688 DOI: 10.1371/Journal.Pone.0046985 |
0.381 |
|
| 2012 |
Ouyang B, Baxter CS, Lam HM, Yeramaneni S, Levin L, Haynes E, Ho SM. Hypomethylation of dual specificity phosphatase 22 promoter correlates with duration of service in firefighters and is inducible by low-dose benzo[a]pyrene. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 54: 774-80. PMID 22796920 DOI: 10.1097/Jom.0B013E31825296Bc |
0.361 |
|
| 2012 |
Walker CL, Ho SM. Developmental reprogramming of cancer susceptibility. Nature Reviews. Cancer. 12: 479-86. PMID 22695395 DOI: 10.1038/Nrc3220 |
0.322 |
|
| 2012 |
Greathouse KL, Bredfeldt T, Everitt JI, Lin K, Berry T, Kannan K, Mittelstadt ML, Ho SM, Walker CL. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Molecular Cancer Research : McR. 10: 546-57. PMID 22504913 DOI: 10.1158/1541-7786.Mcr-11-0605 |
0.35 |
|
| 2012 |
Leung YK, Lee MT, Lam HM, Tarapore P, Ho SM. Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids. 77: 727-37. PMID 22465878 DOI: 10.1016/J.Steroids.2012.03.008 |
0.552 |
|
| 2012 |
Lam HM, Suresh Babu CV, Wang J, Yuan Y, Lam YW, Ho SM, Leung YK. Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion. Molecular and Cellular Endocrinology. 358: 27-35. PMID 22370157 DOI: 10.1016/J.Mce.2012.02.012 |
0.323 |
|
| 2012 |
Isaac J, Lam YW, Tarapore P, Ho S. Abstract B48: Integrin 6 S-nitrosylation induces prostate cancer cell migration by loss of adhesion to laminin-1 Cancer Research. 72: B48-B48. DOI: 10.1158/1538-7445.Prca2012-B48 |
0.399 |
|
| 2011 |
Ho SM, Lee MT, Lam HM, Leung YK. Estrogens and prostate cancer: etiology, mediators, prevention, and management. Endocrinology and Metabolism Clinics of North America. 40: 591-614, ix. PMID 21889723 DOI: 10.1016/J.Ecl.2011.05.002 |
0.617 |
|
| 2011 |
Leung YK, Ho SM. Estrogen receptor β: switching to a new partner and escaping from estrogen. Science Signaling. 4: pe19. PMID 21487104 DOI: 10.1126/Scisignal.2001991 |
0.434 |
|
| 2011 |
Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, Madueke IC, Kajdacsy-Balla A, Prins GS. Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology. 152: 2150-63. PMID 21427218 DOI: 10.1210/en.2010-1377 |
0.306 |
|
| 2011 |
Tarapore P, Shu Y, Guo P, Ho SM. Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 386-94. PMID 21063391 DOI: 10.1038/Mt.2010.243 |
0.305 |
|
| 2010 |
Tam NN, Szeto CY, Freudenberg JM, Fullenkamp AN, Medvedovic M, Ho SM. Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia. Molecular Endocrinology (Baltimore, Md.). 24: 2207-17. PMID 20861223 DOI: 10.1210/me.2010-0179 |
0.422 |
|
| 2010 |
Leung YK, Lam HM, Wu S, Song D, Levin L, Cheng L, Wu CL, Ho SM. Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocrine-Related Cancer. 17: 675-89. PMID 20501637 DOI: 10.1677/Erc-09-0294 |
0.339 |
|
| 2010 |
Zhao H, Ou-Yang F, Chen IF, Hou MF, Yuan SS, Chang HL, Lee YC, Plattner R, Waltz SE, Ho SM, Sims J, Wang SC. Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer. Neoplasia (New York, N.Y.). 12: 214-23. PMID 20234815 DOI: 10.1593/Neo.91576 |
0.596 |
|
| 2010 |
Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death and Differentiation. 17: 1511-23. PMID 20203690 DOI: 10.1038/Cdd.2010.20 |
0.382 |
|
| 2010 |
Lam YW, Yuan Y, Isaac J, Babu CV, Meller J, Ho SM. Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells. Plos One. 5: e9075. PMID 20140087 DOI: 10.1371/Journal.Pone.0009075 |
0.572 |
|
| 2010 |
Joseph D, Ho SM, Syed V. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer. Molecular Cancer Therapeutics. 9: 499-509. PMID 20124444 DOI: 10.1158/1535-7163.Mct-09-0664 |
0.358 |
|
| 2010 |
Zhang X, Wu M, Xiao H, Lee MT, Levin L, Leung YK, Ho SM. Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer. The Prostate. 70: 765-76. PMID 20054818 DOI: 10.1002/Pros.21109 |
0.579 |
|
| 2010 |
Wu T, Wang Y, Ho S, Giovannucci E. Abstract LB-403: Levels of nitric oxide and prostate cancer development in healthy US men enrolled in the Health Professionals Follow-up Study Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-403 |
0.406 |
|
| 2010 |
Zhao HJ, Ou-Yang F, Chen I, Hou M, Yuan SF, Chang H, Lee Y, Plattner R, Waltz S, Ho S, Sims J, Wang S. Abstract LB-179: Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-179 |
0.566 |
|
| 2010 |
Wu T, Giovannucci E, Welge J, Mallick P, LeMasters G, Tang W, Ho S. Abstract 2797: Measurement of GST-P1 methylation in body fluids and prostate cancer diagnosis: a meta-analysis Cancer Research. 70: 2797-2797. DOI: 10.1158/1538-7445.Am10-2797 |
0.388 |
|
| 2009 |
Xiong SD, Yu K, Liu XH, Yin LH, Kirschenbaum A, Yao S, Narla G, DiFeo A, Wu JB, Yuan Y, Ho SM, Lam YW, Levine AC. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. International Journal of Cancer. 125: 774-82. PMID 19384952 DOI: 10.1002/Ijc.24325 |
0.417 |
|
| 2009 |
Ouyang B, Bracken B, Burke B, Chung E, Liang J, Ho SM. A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer. The Journal of Urology. 181: 2508-13; discussion . PMID 19371911 DOI: 10.1016/J.Juro.2009.01.110 |
0.398 |
|
| 2009 |
Zhang X, Leav I, Revelo MP, Deka R, Medvedovic M, Jiang Z, Ho SM. Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon. Plos Genetics. 5: e1000334. PMID 19148275 DOI: 10.1371/Journal.Pgen.1000334 |
0.384 |
|
| 2009 |
Schiewer MJ, Morey LM, Burd CJ, Liu Y, Merry DE, Ho SM, Knudsen KE. Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer Oncogene. 28: 1016-1027. PMID 19079343 DOI: 10.1038/Onc.2008.446 |
0.406 |
|
| 2009 |
Estes MD, Ouyang B, Ho S, Ahn CH. Isolation of prostate cancer cell subpopulations of functional interest by use of an on-chip magnetic bead-based cell separator Journal of Micromechanics and Microengineering. 19: 095015. DOI: 10.1088/0960-1317/19/9/095015 |
0.349 |
|
| 2008 |
Bakshi S, Zhang X, Godoy-Tundidor S, Cheng RY, Sartor MA, Medvedovic M, Ho SM. Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor. Environmental Health Perspectives. 116: 769-76. PMID 18560533 DOI: 10.1289/Ehp.11215 |
0.385 |
|
| 2008 |
Lam YW, Tam NN, Evans JE, Green KM, Zhang X, Ho SM. Differential proteomics in the aging Noble rat ventral prostate. Proteomics. 8: 2750-63. PMID 18546156 DOI: 10.1002/Pmic.200700986 |
0.376 |
|
| 2008 |
Tam NN, Szeto CY, Sartor MA, Medvedovic M, Ho SM. Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats. Neoplasia (New York, N.Y.). 10: 20-40. PMID 18231636 DOI: 10.1593/Neo.07889 |
0.418 |
|
| 2008 |
Prins GS, Tang WY, Belmonte J, Ho SM. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic & Clinical Pharmacology & Toxicology. 102: 134-8. PMID 18226066 DOI: 10.1111/j.1742-7843.2007.00166.x |
0.315 |
|
| 2008 |
Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. American Journal of Respiratory and Critical Care Medicine. 177: 567-73. PMID 18187692 DOI: 10.1164/Rccm.200710-1511Pp |
0.303 |
|
| 2008 |
Choubey D, Deka R, Ho SM. Interferon-inducible IFI16 protein in human cancers and autoimmune diseases. Frontiers in Bioscience : a Journal and Virtual Library. 13: 598-608. PMID 17981573 DOI: 10.2741/2705 |
0.369 |
|
| 2007 |
Alimirah F, Panchanathan R, Chen J, Zhang X, Ho SM, Choubey D. Expression of androgen receptor is negatively regulated by p53. Neoplasia (New York, N.Y.). 9: 1152-9. PMID 18084622 DOI: 10.1593/Neo.07769 |
0.388 |
|
| 2007 |
Hess-Wilson JK, Webb SL, Daly HK, Leung YK, Boldison J, Comstock CE, Sartor MA, Ho SM, Knudsen KE. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Environmental Health Perspectives. 115: 1646-53. PMID 18007998 DOI: 10.1289/Ehp.10283 |
0.453 |
|
| 2007 |
Tam NN, Leav I, Ho SM. Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. The American Journal of Pathology. 171: 1334-41. PMID 17717140 DOI: 10.2353/Ajpath.2007.070199 |
0.367 |
|
| 2007 |
Syed V, Mukherjee K, Godoy-Tundidor S, Ho SM. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. Journal of Cellular Biochemistry. 102: 442-52. PMID 17393432 DOI: 10.1002/Jcb.21304 |
0.302 |
|
| 2006 |
Languino LR, Ho SM. Androgen action series. Journal of Cellular Biochemistry. 99: 331-2. PMID 17632872 DOI: 10.1002/Jcb.21062 |
0.3 |
|
| 2006 |
Ho SM, Leung YK, Chung I. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Annals of the New York Academy of Sciences. 1089: 177-93. PMID 17261766 DOI: 10.1196/Annals.1386.005 |
0.437 |
|
| 2006 |
Mak P, Leung YK, Tang WY, Harwood C, Ho SM. Apigenin suppresses cancer cell growth through ERbeta. Neoplasia (New York, N.Y.). 8: 896-904. PMID 17132221 DOI: 10.1593/neo.06538 |
0.323 |
|
| 2006 |
Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Research. 66: 8542-9. PMID 16951166 DOI: 10.1158/0008-5472.Can-06-0294 |
0.392 |
|
| 2006 |
Leung YK, Gao Y, Lau KM, Zhang X, Ho SM. ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalk. Neoplasia (New York, N.Y.). 8: 242-9. PMID 16756716 DOI: 10.1593/Neo.05853 |
0.382 |
|
| 2006 |
Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Research. 66: 5624-32. PMID 16740699 DOI: 10.1158/0008-5472.CAN-06-0516 |
0.352 |
|
| 2006 |
Tam NN, Nyska A, Maronpot RR, Kissling G, Lomnitski L, Suttie A, Bakshi S, Bergman M, Grossman S, Ho SM. Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants. The Prostate. 66: 57-69. PMID 16114064 DOI: 10.1002/Pros.20313 |
0.362 |
|
| 2005 |
Syed V, Zhang X, Lau KM, Cheng R, Mukherjee K, Ho SM. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene. 24: 8128-43. PMID 16116479 DOI: 10.1038/Sj.Onc.1208959 |
0.345 |
|
| 2005 |
Lam YW, Mobley JA, Evans JE, Carmody JF, Ho SM. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer. Proteomics. 5: 2927-38. PMID 15952230 DOI: 10.1002/Pmic.200401165 |
0.305 |
|
| 2005 |
Leung YK, Lau KM, Mobley J, Jiang Z, Ho SM. Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis. Cancer Research. 65: 3726-34. PMID 15867368 DOI: 10.1158/0008-5472.Can-04-3771 |
0.346 |
|
| 2005 |
Mukherjee K, Syed V, Ho SM. Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells. Oncogene. 24: 4388-400. PMID 15806153 DOI: 10.1038/Sj.Onc.1208623 |
0.373 |
|
| 2005 |
Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, Tsuruo T, Ho SM. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene. 24: 1774-87. PMID 15674352 DOI: 10.1038/Sj.Onc.1207991 |
0.336 |
|
| 2004 |
Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B. Human prostate cancer risk factors. Cancer. 101: 2371-490. PMID 15495199 DOI: 10.1002/Cncr.20408 |
0.391 |
|
| 2004 |
Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Metastases of prostate cancer express estrogen receptor-beta. Urology. 64: 814-20. PMID 15491740 DOI: 10.1016/j.urology.2004.05.036 |
0.348 |
|
| 2004 |
Mobley JA, Lam YW, Lau KM, Pais VM, L'Esperance JO, Steadman B, Fuster LM, Blute RD, Taplin ME, Ho SM. Monitoring the serological proteome: the latest modality in prostate cancer detection. The Journal of Urology. 172: 331-7. PMID 15201806 DOI: 10.1097/01.Ju.0000132355.97888.50 |
0.367 |
|
| 2004 |
Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE, Ho SM. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. The American Journal of Pathology. 164: 2003-12. PMID 15161636 DOI: 10.1016/S0002-9440(10)63760-1 |
0.39 |
|
| 2004 |
Ho SM. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. Journal of Cellular Biochemistry. 91: 491-503. PMID 14755680 DOI: 10.1002/Jcb.10759 |
0.44 |
|
| 2004 |
Wu M, Ho SM. PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model. Oncogene. 23: 250-9. PMID 14712230 DOI: 10.1038/Sj.Onc.1207076 |
0.388 |
|
| 2003 |
Tam NN, Gao Y, Leung YK, Ho SM. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. The American Journal of Pathology. 163: 2513-22. PMID 14633623 DOI: 10.1016/S0002-9440(10)63606-1 |
0.399 |
|
| 2003 |
Ho SM. Estrogen, progesterone and epithelial ovarian cancer. Reproductive Biology and Endocrinology : Rb&E. 1: 73. PMID 14577831 DOI: 10.1186/1477-7827-1-73 |
0.347 |
|
| 2003 |
Syed V, Ho SM. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Oncogene. 22: 6883-90. PMID 14534535 DOI: 10.1038/Sj.Onc.1206828 |
0.304 |
|
| 2003 |
Kwong J, Lui K, Chan PS, Ho SM, Wong YC, Xuan JW, Chan FL. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates. The Prostate. 56: 81-97. PMID 12746832 DOI: 10.1002/Pros.10228 |
0.37 |
|
| 2003 |
Lau KM, Tam NN, Thompson C, Cheng RY, Leung YK, Ho SM. Age-associated changes in histology and gene-expression profile in the rat ventral prostate. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 743-57. PMID 12746483 DOI: 10.1097/01.Lab.0000069519.06988.24 |
0.376 |
|
| 2003 |
Leav I, McNeal JE, Ho SM, Jiang Z. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Human Pathology. 34: 228-33. PMID 12673556 DOI: 10.1053/Hupa.2003.42 |
0.377 |
|
| 2003 |
Tam NN, Ghatak S, Ho SM. Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats. The Prostate. 55: 1-8. PMID 12640655 DOI: 10.1002/Pros.10169 |
0.389 |
|
| 2003 |
Ho SM, Lau KM. DNA microarrays in prostate cancer. Current Urology Reports. 3: 53-60. PMID 12084220 DOI: 10.1007/S11934-002-0011-X |
0.372 |
|
| 2002 |
Thompson CJ, Tam NN, Joyce JM, Leav I, Ho SM. Gene Expression Profiling of Testosterone and Estradiol-17β-Induced Prostatic Dysplasia in Noble Rats and Response to the Antiestrogen ICI 182,780. Endocrinology. 143: 2093-2105. PMID 28204429 DOI: 10.1210/Endo.143.6.8846 |
0.369 |
|
| 2002 |
Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. The Prostate. 52: 69-81. PMID 11992621 DOI: 10.1002/Pros.10103 |
0.42 |
|
| 2002 |
Tekur S, Ho SM. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines. Molecular Carcinogenesis. 33: 44-55. PMID 11807957 DOI: 10.1002/Mc.10017 |
0.402 |
|
| 2001 |
Li SC, Chen GF, Chan PSF, Choi HL, Ho S, Chan FL. Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. The Prostate. 49: 58-71. PMID 11550211 DOI: 10.1002/Pros.1118 |
0.385 |
|
| 2001 |
Taplin ME, Ho S. The Endocrinology of Prostate Cancer The Journal of Clinical Endocrinology and Metabolism. 86: 3467-3477. PMID 11502765 DOI: 10.1210/Jcem.86.8.7782 |
0.397 |
|
| 2001 |
Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. The American Journal of Pathology. 159: 79-92. PMID 11438457 DOI: 10.1016/S0002-9440(10)61676-8 |
0.402 |
|
| 2001 |
Tekur S, Lau KM, Long J, Burnstein K, Ho SM. Expression of RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: regulation by methylation and sex steroids. Molecular Carcinogenesis. 30: 1-13. PMID 11255259 DOI: 10.1002/1098-2744(200101)30:1<1::Aid-Mc1008>3.0.Co;2-X |
0.451 |
|
| 2001 |
Chan FL, Choi HL, Ho S. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and protein blotting. The Prostate. 46: 21-32. PMID 11170128 DOI: 10.1002/1097-0045(200101)46:1<21::Aid-Pros1004>3.0.Co;2-G |
0.415 |
|
| 2000 |
Kwong J, Xuan JW, Chan PS, Ho SM, Chan FL. A Comparative Study of Hormonal Regulation of Three Secretory Proteins (Prostatic Secretory Protein-PSP94, Probasin, and Seminal Vesicle Secretion II) in Rat Lateral Prostate* *This work was supported by an RGC Earmarked Research Grant (CUHK 4131/00M) from the Hong Kong Research Grant Council (to F.L.C.) and a grant from the Medical Research Council of Canada (to J.W.X.). Endocrinology. 141: 4543-4551. PMID 28201023 DOI: 10.1210/Endo.141.12.7818 |
0.38 |
|
| 1999 |
Lee K, Lau K, Ho S. Generation and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid Toxicology and Applied Pharmacology. 161: 294-301. PMID 10620487 DOI: 10.1006/Taap.1999.8821 |
0.305 |
|
| 1999 |
Leav I, Merk FB, Lee KF, Loda M, Mandoki M, McNeal JE, Ho S. Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions American Journal of Pathology. 154: 863-870. PMID 10079264 DOI: 10.1016/S0002-9440(10)65333-3 |
0.393 |
|
| 1999 |
Chan FL, Ho S. Comparative study of glycoconjugates of the rat prostatic lobes by lectin histochemistry. The Prostate. 38: 1-16. PMID 9973104 DOI: 10.1002/(Sici)1097-0045(19990101)38:1<1::Aid-Pros1>3.0.Co;2-6 |
0.397 |
|
| 1999 |
Lee K, Lau K, Ho S. Effects of cadmium on metallothionein-I and metallothionein-II mRNA expression in rat ventral, lateral, and dorsal prostatic lobes: quantification by competitive RT-PCR. Toxicology and Applied Pharmacology. 154: 20-27. PMID 9882588 DOI: 10.1006/Taap.1998.8556 |
0.326 |
|
| 1998 |
Lau KM, Leav I, Ho SM. Rat Estrogen Receptor-α and -β, and Progesterone Receptor mRNA Expression in Various Prostatic Lobes and Microdissected Normal and Dysplastic Epithelial Tissues of the Noble Rats. Endocrinology. 139: 424-427. PMID 28200501 DOI: 10.1210/Endo.139.1.5809 |
0.402 |
|
| 1998 |
Ho S, Leav I, Ghatak S, Merk F, Jagannathan VS, Mallery K. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat. American Journal of Pathology. 153: 131-139. PMID 9665473 DOI: 10.1016/S0002-9440(10)65553-8 |
0.405 |
|
| 1997 |
Lane KE, Ricci MJ, Ho SM. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats. The Prostate. 30: 256-62. PMID 9111603 DOI: 10.1002/(Sici)1097-0045(19970301)30:4<256::Aid-Pros5>3.0.Co;2-J |
0.359 |
|
| 1996 |
Ho S, Lane K. Sex hormone-induction and dietary modulation of Prostatic Adenocarcinoma (PA) in animal models. Urologic Oncology-Seminars and Original Investigations. 2: 110-115. PMID 21224149 DOI: 10.1016/S1078-1439(97)82841-4 |
0.358 |
|
| 1996 |
Kaplan PJ, Leav I, Greenwood J, Kwan PWL, Ho S. Involvement of transforming growth factor α (TGFα) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate Carcinogenesis. 17: 2571-2579. PMID 9006091 DOI: 10.1093/Carcin/17.12.2571 |
0.363 |
|
| 1996 |
Ghatak S, Oliveria P, Kaplan P, Ho S. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate The Prostate. 29: 91-100. PMID 8700805 DOI: 10.1002/(Sici)1097-0045(199608)29:2<91::Aid-Pros4>3.0.Co;2-K |
0.418 |
|
| 1996 |
Ghatak S, Ho S. Age-related changes in the activities of antioxidant enzymes and lipid peroxidation status in ventral and dorsolateral prostate lobes of noble rats. Biochemical and Biophysical Research Communications. 222: 362-367. PMID 8670210 DOI: 10.1006/Bbrc.1996.0749 |
0.349 |
|
| 1995 |
Ho SM, Yu M. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats. The Journal of Steroid Biochemistry and Molecular Biology. 52: 233-8. PMID 7696144 DOI: 10.1016/0960-0760(94)00170-Q |
0.36 |
|
| 1994 |
Ho S, Roy D. Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolaterel prostates of Noble rats Cancer Letters. 84: 155-162. PMID 8076372 DOI: 10.1016/0304-3835(94)90370-0 |
0.363 |
|
| 1993 |
Ho SM, Viccione T, Yu M. In vitro and in vivo inhibition of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats. The Journal of Steroid Biochemistry and Molecular Biology. 46: 489-95. PMID 8217879 DOI: 10.1016/0960-0760(93)90103-4 |
0.359 |
|
| 1991 |
Ho SM. Prostatic androgen receptor and plasma testosterone levels in streptozotocin-induced diabetic rats Journal of Steroid Biochemistry and Molecular Biology. 38: 67-72. PMID 1825471 DOI: 10.1016/0960-0760(91)90402-Q |
0.365 |
|
| 1989 |
Leav I, Merk FB, Kwan PW‐, Ho S. Androgen‐supported estrogen‐enhanced epithelial proliferation in the prostates of intact noble rats The Prostate. 15: 23-40. PMID 2477830 DOI: 10.1002/Pros.2990150104 |
0.377 |
|
| 1988 |
Ho S, Fehrer S, Yu M, Liang L, Press D. High-affinity binding of [3H]estradiol-17β by an estrogen receptor in the liver of the turtle☆ General and Comparative Endocrinology. 70: 382-394. PMID 3417113 DOI: 10.1016/0016-6480(88)90112-8 |
0.303 |
|
| 1988 |
Leav I, Ho S, Ofner P, Merk FB, Kwan PW, Damassa D. Biochemical Alterations in Sex Hormone-Induced Hyperplasia and Dysplasia of the Dorsolateral Prostates of Noble Rats, Journal of the National Cancer Institute. 80: 1045-1053. PMID 2457709 DOI: 10.1093/Jnci/80.13.1045 |
0.375 |
|
| 1987 |
Ho SM, Ofner P. Prostatic cytosol binding of 5 alpha-androstane-3 beta, 17 beta-diol and estradiol-17 beta. Steroids. 47: 21-34. PMID 3810696 DOI: 10.1016/0039-128X(86)90073-5 |
0.325 |
|
| 1987 |
Ho S, Press D, Liang L, Sower S. Identification of an estrogen receptor in the testis of the sea lamprey, Petromyzon marinus. General and Comparative Endocrinology. 67: 119-125. PMID 3623065 DOI: 10.1016/0016-6480(87)90211-5 |
0.323 |
|
| 1985 |
Ho S, Damassa D, Kwan PWL, Seto HSK, Leav I. Androgen receptor levels and androgen contents in the prostate lobes of intact and testosterone-treated Noble rats. Journal of Andrology. 6: 279-290. PMID 3877039 DOI: 10.1002/J.1939-4640.1985.Tb00846.X |
0.395 |
|
| Show low-probability matches. |